Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ST500
- Development stage
- Unknown
- Administration
- Topical
01
Overview
ST500 is a topical therapeutic product evaluated for improving pain and function in patients with tendon injury of the long head of the biceps tendon (LHBT). In a post-market interventional single-arm clinical study, a 6-week topical application of ST500 resulted in significant improvements in pain, constant-murley score (CMS), and range of motion (ROM) in affected shoulders. The product was safe and well-tolerated, with only mild local swelling reported in one patient. Mechanism of action details, molecular composition, or pharmacological target are not provided in the available sources.
- Brand names
- ST500ST-500ST 500
- Other names
- ST500ST-500ST 500
Beyond the preview
Go deeper on ST500.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ST500.